270 related articles for article (PubMed ID: 21544511)
1. Functional selectivity of adenosine receptor ligands.
Verzijl D; Ijzerman AP
Purinergic Signal; 2011 Jun; 7(2):171-92. PubMed ID: 21544511
[TBL] [Abstract][Full Text] [Related]
2. Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands.
Leduc M; Breton B; Galés C; Le Gouill C; Bouvier M; Chemtob S; Heveker N
J Pharmacol Exp Ther; 2009 Oct; 331(1):297-307. PubMed ID: 19584306
[TBL] [Abstract][Full Text] [Related]
3. Arylpiperazine agonists of the serotonin 5-HT1A receptor preferentially activate cAMP signaling versus recruitment of β-arrestin-2.
Stroth N; Niso M; Colabufo NA; Perrone R; Svenningsson P; Lacivita E; Leopoldo M
Bioorg Med Chem; 2015 Aug; 23(15):4824-4830. PubMed ID: 26081758
[TBL] [Abstract][Full Text] [Related]
4. Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor.
Kurko D; Kapui Z; Nagy J; Lendvai B; Kolok S
Brain Res Bull; 2014 Aug; 107():89-101. PubMed ID: 25080296
[TBL] [Abstract][Full Text] [Related]
5. Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling.
Emery AC; DiRaddo JO; Miller E; Hathaway HA; Pshenichkin S; Takoudjou GR; Grajkowska E; Yasuda RP; Wolfe BB; Wroblewski JT
Mol Pharmacol; 2012 Aug; 82(2):291-301. PubMed ID: 22584219
[TBL] [Abstract][Full Text] [Related]
6. Functional selectivity of adenosine A1 receptor ligands?
Langemeijer EV; Verzijl D; Dekker SJ; Ijzerman AP
Purinergic Signal; 2013 Mar; 9(1):91-100. PubMed ID: 23054444
[TBL] [Abstract][Full Text] [Related]
7. beta-arrestin-biased agonism at the beta2-adrenergic receptor.
Drake MT; Violin JD; Whalen EJ; Wisler JW; Shenoy SK; Lefkowitz RJ
J Biol Chem; 2008 Feb; 283(9):5669-76. PubMed ID: 18086673
[TBL] [Abstract][Full Text] [Related]
8. Biased agonism at the parathyroid hormone receptor: a demonstration of functional selectivity in bone metabolism.
Bohinc BN; Gesty-Palmer D
Mini Rev Med Chem; 2012 Aug; 12(9):856-65. PubMed ID: 22681253
[TBL] [Abstract][Full Text] [Related]
9. Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors.
Lymperopoulos A
Curr Pharm Des; 2012; 18(2):192-8. PubMed ID: 22229558
[TBL] [Abstract][Full Text] [Related]
10. β-arrestins and biased signaling in gonadotropin receptors.
De Pascali F; Reiter E
Minerva Ginecol; 2018 Oct; 70(5):525-538. PubMed ID: 29999287
[TBL] [Abstract][Full Text] [Related]
11. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574
[TBL] [Abstract][Full Text] [Related]
12. Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.
Seyedabadi M; Ghahremani MH; Albert PR
Pharmacol Ther; 2019 Aug; 200():148-178. PubMed ID: 31075355
[TBL] [Abstract][Full Text] [Related]
13. Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.
Allen JA; Yost JM; Setola V; Chen X; Sassano MF; Chen M; Peterson S; Yadav PN; Huang XP; Feng B; Jensen NH; Che X; Bai X; Frye SV; Wetsel WC; Caron MG; Javitch JA; Roth BL; Jin J
Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18488-93. PubMed ID: 22025698
[TBL] [Abstract][Full Text] [Related]
14. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
Conroy JL; Free RB; Sibley DR
ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
[TBL] [Abstract][Full Text] [Related]
15. Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7.
Rajagopal S; Kim J; Ahn S; Craig S; Lam CM; Gerard NP; Gerard C; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):628-32. PubMed ID: 20018651
[TBL] [Abstract][Full Text] [Related]
16. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
[TBL] [Abstract][Full Text] [Related]
17. Experimental and computational analysis of biased agonism on full-length and a C-terminally truncated adenosine A
Navarro G; Gonzalez A; Campanacci S; Rivas-Santisteban R; Reyes-Resina I; Casajuana-Martin N; Cordomí A; Pardo L; Franco R
Comput Struct Biotechnol J; 2020; 18():2723-2732. PubMed ID: 33101610
[TBL] [Abstract][Full Text] [Related]
18. Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity.
Peterson SM; Pack TF; Caron MG
PLoS One; 2015; 10(10):e0141637. PubMed ID: 26516769
[TBL] [Abstract][Full Text] [Related]
19. Comparative analyses of downstream signal transduction targets modulated after activation of the AT1 receptor by two β-arrestin-biased agonists.
Santos GA; Duarte DA; Parreiras-E-Silva LT; Teixeira FR; Silva-Rocha R; Oliveira EB; Bouvier M; Costa-Neto CM
Front Pharmacol; 2015; 6():131. PubMed ID: 26191004
[TBL] [Abstract][Full Text] [Related]
20. Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.
M'Kadmi C; Leyris JP; Onfroy L; Galés C; Saulière A; Gagne D; Damian M; Mary S; Maingot M; Denoyelle S; Verdié P; Fehrentz JA; Martinez J; Banères JL; Marie J
J Biol Chem; 2015 Nov; 290(45):27021-27039. PubMed ID: 26363071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
